India to United States: Lapatinib Export Trade Route
India has recorded 14 verified shipments of Lapatinib exported to United States, representing a combined trade value of $1.7M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $121.0K USD. The leading Indian exporter is NATCO PHARMA LIMITED, which accounts for 100% of total export value with 12 shipments worth $1.7M USD. On the buying side, UPS is the largest importer in United States with $852.1K USD in purchases. The top 3 suppliers — NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Lapatinib corridor is one of India's established pharmaceutical export routes, with 14 shipments documented worth a combined $1.7M USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $121.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with lapatinib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 24.9%, placing it at rank #18 among India's top lapatinib export destinations globally.
On the import side, key buyers of Indian lapatinib in United States include UPS, UPS SUPPLY CHAIN SOLUTIONS, NA and 1 others. UPS is the single largest importer with 7 shipments valued at $852.1K USD.
Route Characteristics
- Average transit32 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD AIR
Market Position
- Global rank#18
- Annual growth+24.9%
- Demand growth+22.8%
- Regulatory ease83/100
Top 10 Indian Lapatinib Exporters to United States
Showing top 10 of 3 Indian suppliers exporting Lapatinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED Avg $141.0K per shipment | 12 | $1.7M | 99.9% |
| 2 | VINAYAK ASSOCIATES Avg $1.2K per shipment | 1 | $1.2K | 0.1% |
| 3 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $161 per shipment | 1 | $161 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting lapatinib to United States, ranked by total trade value. The listed exporters are: NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED. NATCO PHARMA LIMITED is the dominant supplier with 12 shipments worth $1.7M USD, giving it a 100% market share.
Top 10 Lapatinib Importers in United States
Showing top 10 of 4 known buyers in United States receiving Lapatinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian lapatinib in United States include UPS, UPS SUPPLY CHAIN SOLUTIONS, NA, TO THE ORDER OF. The largest importer is UPS, accounting for $852.1K USD across 7 shipments — representing 50% of all lapatinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UPS | 7 | $852.1K | 50.3% |
| 2 | UPS SUPPLY CHAIN SOLUTIONS | 5 | $840.2K | 49.6% |
| 3 | NA | 1 | $1.2K | 0.1% |
| 4 | TO THE ORDER OF | 1 | $161 | 0.0% |
Top 10 Lapatinib Formulations Imported by United States
Showing top 10 of 8 product formulations shipped on the India to United States Lapatinib route, ranked by trade value
United States imports a wide range of lapatinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LAPATINIB 250MG, TABLETS 150S (752 X 150S) (OTHER REF CI NO: 123241) (APPENDIX 4R,RODTEP ENTRY NO:10153)NOS — accounts for $350.0K USD across 3 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LAPATINIB 250MG, TABLETS 150S (752 X 150S) (OTHER REF CI NO: 123241) (APPENDIX 4R,RODTEP ENTRY NO:10153)NOS | 3 | $350.0K | 20.7% |
| 2 | LAPATINIB 250 MG TABLETS (735 X 150'S) | 3 | $342.1K | 20.2% |
| 3 | TABLETS : LAPATINIB 250 MG 150'S (730X150'S) (APPENDIX 4R) (RODTEP ENTRY NO. : 10153) (OUR REF. NO. : 125020) | 1 | $336.2K | 19.8% |
| 4 | LAPATINIB 250MG, TABLETS 150S (716 X 150S) (OTHER REF CI NO: 123242) (APPENDIX 4R,RODTEP ENTRY NO:10153)NOS | 3 | $333.2K | 19.7% |
| 5 | LAPATINIB 250MG TABLETS 150'S - QTY : | 1 | $168.9K | 10.0% |
| 6 | TABLETS : LAPATINIB 250 MG 150'S (357X150'S) (APPENDIX 4R) (RODTEP ENTRY NO. : 10153) (OUR REF. NO. : 124225) | 1 | $162.0K | 9.6% |
| 7 | LAPATINIB 250MG TABLETS 1*30 PACK (TY) BATCH: T23I008B / EXPIRY: 31-AUG-25PCS | 1 | $1.2K | 0.1% |
| 8 | LAPATINIB 250MG TABLETS PRODUCT NAME: HERTAB (PACK SIZE : 2 X 1 PACK OF 30 TABLETS)NOS | 1 | $161 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD AIR handles the highest volume with 6 shipments. Transit time averages 32 days by sea.
Market Dynamics
India's lapatinib exports to United States are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $121.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lapatinib 250 mg tablets (735 x 150's) and tablets : lapatinib 250 mg 150's (730x150's) (appendix 4r) (rodtep entry no. : 10153) (our ref. no. : 125020), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UPS is the largest importer with 7 shipments worth $852.1K USD — representing 50% of all lapatinib imports from India on this route.
Route Statistics
- Trade Volume
- $1.7M
- Avg. Shipment
- $121.0K
- Suppliers
- 3
- Buyers
- 4
- Transit (Sea)
- ~32 days
- Annual Growth
- +24.9%
Other Lapatinib Routes
Unlock the Full India to United States Lapatinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 14 shipments on this route.
Frequently Asked Questions — India to United States Lapatinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Lapatinib to United States?
The leading Indian exporters of Lapatinib to United States are NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, GLOBYZ BIOPHARMA PRIVATE LIMITED. NATCO PHARMA LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Lapatinib exports from India to United States?
India exports Lapatinib to United States worth approximately $1.7M USD across 14 recorded shipments. The average value per shipment is $121.0K USD.
Q Which ports does India use to ship Lapatinib to United States?
The most active port of origin is HYDERABAD AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Lapatinib?
The average transit time for Lapatinib shipments from India to United States is approximately 32 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Lapatinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 24.9% with demand growth tracking at 22.8%. The route is ranked #18 among India's top Lapatinib export destinations globally.
Q How many suppliers are active on the India to United States Lapatinib route?
There are currently 3 active Indian suppliers exporting Lapatinib to United States. The market is moderately concentrated with NATCO PHARMA LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Lapatinib from India in United States?
The leading importers of Indian Lapatinib in United States include UPS, UPS SUPPLY CHAIN SOLUTIONS, NA, TO THE ORDER OF. UPS is the largest buyer with 7 shipments worth $852.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Lapatinib.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 4 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 14 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
14 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists